기본 콘텐츠로 건너뛰기

📊 Comparing 3 China Tech ETFs: DRAG vs. TIGER China Tech Top10 vs. KODEX China Tech Top10 — Which Strategy Fits You?

With valuations for Chinese tech stocks still appearing attractive, I explored three ETFs that take different strategic approaches to China's growth potential. Previously, I introduced the U.S.-listed DRAG ETF, and recently, Mirae Asset’s TIGER China Tech Top10 and Samsung Asset Management’s KODEX China Tech Top10 were listed on the Korean exchange. All three focus on concentrated portfolios of selected large-cap Chinese tech stocks—but their investment strategies differ significantly, and that’s what I want to highlight.

The previous post is linked below ⬇️

China Stock Market Valuation 

DRAG ETF : China Tech Leader ETF


1️⃣ Roundhill China Dragons ETF (DRAG)

U.S.-listed | Focused investment in select Chinese tech giants

  • AUM: $30.06M (₩41.3B approx., as of June 19, 2025)
  • NAV: $25.01
  • Volume: 2,293 shares (as of June 12, 2025)
  • Expense Ratio: 0.59%
  • No. of Holdings: 6
  • Strategy: Active
  • Top Holdings: Tencent, Alibaba, Xiaomi, BYD, Pinduoduo, Meituan

🔎 Key Features
→ Ultra-concentrated portfolio of 5–10 leading Chinese tech names
→ Focus on globally competitive companies like Tencent, Xiaomi, Alibaba, and BYD
→ Higher exposure to individual stock risk, but centered on vetted large caps
→ ADR-based, offering strong accessibility to U.S. investors


2️⃣ TIGER China Tech Top10 ETF

Korea-listed | Passive ETF with broad exposure to advanced tech sectors

  • AUM: ₩101.1B (as of June 19, 2025)
  • NAV: ₩9,250
  • Volume: 114,937 shares
  • Expense Ratio: 0.49%
  • No. of Holdings: 10
  • Strategy: Passive (Index-tracking)
  • Top Holdings: Xiaomi, Tencent, CATL, Meituan, Alibaba

🔎 Key Features
→ Tracks the proprietary China Tech Top10 index by Mirae Asset
→ Diversified across high-tech sectors: batteries, semiconductors, medical devices, AI, cloud
→ Weighted by market capitalization, reflecting market trends
→ Lower concentration risk thanks to diversified allocation


3️⃣ KODEX China Tech Top10 ETF

Korea-listed | Passive ETF focused on policy-supported and stable growth

  • AUM: ₩70.2B (as of June 19, 2025)
  • NAV: ₩9,815
  • Volume: 51,310 shares
  • Expense Ratio: 0.45%
  • No. of Holdings: 10
  • Strategy: Passive (Index-tracking)
  • Top Holdings: Tencent, Alibaba, BYD, Xiaomi

🔎 Key Features
→ Tracks the Hang Seng China Tech Top10 Index
→ Focus on companies aligned with Chinese government-supported sectors (EVs, AI, semiconductors, cloud)
→ A balanced and stable tech portfolio incorporating both policy beneficiaries and global leaders
→ More diversification than DRAG, but with more recognizable names than TIGER


🔍 ETF Comparison Summary

Category DRAG
(U.S., Roundhill)		 TIGER
(KRX, Mirae Asset)		 KODEX
(KRX, Samsung Asset)
Strategy Active Passive
(Mirae Asset’s Tech Top10 Index)

 Passive
(Hang Seng Tech Top10 Index)
Portfolio Size 6 holdings
(large-cap tech only)

 10 holdings
(broad tech sectors)

 10 holdings
(policy-driven focus)
Weighting Approach Equal Weight Market-cap Weighted Max 15% per holding
Key Stocks
Tencent, Alibaba, BYD, Xiaomi		 CATL, SMIC, Lenovo, Kingsoft, etc. Tencent, BYD, Xiaomi, Alibaba
Listing Venue
U.S. CBOE (ADR-based)		 Korea KRX Korea KRX
Expense Ratio 0.59% 0.49% 0.45%
Investment Focus Global competitiveness, few winners
Thematic diversification in high tech		 Strategically aligned with industrial policy


✅ So... Which ETF Fits You Best?

  • DRAG: “I want to bet big on winners like Tencent and BYD” → Highly focused, global exposure
  • TIGER: “I prefer a thematic spread across AI, semiconductors, and cloud” → Diversified tech play
  • KODEX: “I trust government-backed growth stories in China” → Policy-aligned and stable

While all three ETFs share the concept of concentrated exposure to China’s tech sector, each embodies a different investment philosophy and strategic approach. If you believe in high-conviction, globally dominant players—go with DRAG. If you seek broad tech diversification, consider TIGER. And if you're aligning with government policy and stability, KODEX might be your best fit.


라벨:

댓글

댓글 쓰기

이 블로그의 인기 게시물

Why Did HIMS Stock Crash? A Deep Dive into Digital Healthcare Risks

The digital healthcare industry is growing rapidly, but it comes with significant risks. Recently, U.S.-based telehealth company Hims & Hers Health (HIMS) experienced a sharp stock drop, raising red flags for investors. This post explores HIMS’s business model, recent developments, and future outlook. What is Hims & Hers Health (HIMS)   Hims & Hers Health Inc. is a U.S. digital healthcare company offering a wide range of online health solutions( Hair loss treatment, Skin care, Sexual health, Mental health, Wellness (e.g., sleep aids, vitamins, weight management) ) . Through its platform, users complete a brief questionnaire via website or mobile app, which is reviewed by licensed professionals. If approved, prescriptions are delivered to the customer’s home. Some products are also available over-the-counter.  Why Is HIMS Popular?   HIMS operates on a Direct-to-Consumer (D2C) model , with most products offered via monthly subscriptions . This approach...
댓글 쓰기
자세한 내용 보기

Analysis of U.S. Healthcare Trends: Which Sectors Are Thriving?

 The U.S. healthcare industry is evolving rapidly, influenced by policy changes and technological innovation. The restructuring of healthcare under the Trump administration, along with the expansion of Health Services & Technology (HST) and Specialty Pharmacies , are key developments shaping the market. 1. Overview of the U.S. Healthcare System Unlike South Korea, the U.S. does not have a universal national health insurance system . Instead, it operates on a private insurance-driven healthcare model. Healthcare costs in the U.S. are among the highest in the world, and without insurance, patients face exorbitant medical expenses. As a result, private health insurance is essential, and many companies offer employee benefits that include health coverage. This has led to a highly competitive and active private insurance market . As of 2023, 17.6% of the U.S. population is aged 65 or older , and the average life expectancy is 79.3 years . Meanwhile, the mortality rate has decli...
댓글 쓰기
자세한 내용 보기